https://newsletter.po.creamermedia.com
Deepening Democracy through Access to Information
Home / News / All News RSS ← Back
Africa|Health|Risk Management|Products
Africa|Health|Risk Management|Products
africa|health|risk-management|products
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

Covid-19: Current vaccination is an expanded trial study, says Khumbudzo Ntshavheni


Close

Embed Video

Covid-19: Current vaccination is an expanded trial study, says Khumbudzo Ntshavheni

Acting Minister in the Presidency Khumbudzo Ntshavheni
Acting Minister in the Presidency Khumbudzo Ntshavheni

3rd March 2021

By: News24Wire

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

The government has maintained the recent vaccination of health workers across the country is an expanded trial study.

Acting Minister in the Presidency Khumbudzo Ntshavheni told the media the government had never claimed the vaccination process underway was a full rollout.

Advertisement

Ntshavheni and Deputy Health Minister Joe Phaahla was accompanying Deputy President David Mabuza on a visit to the Biovac Institute in Midrand.

The facility is used to store and distribute the Johnson & Johnson vaccine.

Advertisement

"Government has never claimed it is a full rollout. We have said it is an expanded trial study that is being done. That is why it is health workers participating in that study," said Ntshavheni.

He added the government was responsible for administering the vaccine, saying the Pfizer vaccine would have to go through the necessary regulatory authorisation via the SA Health Products Regulatory Authority (SAHPRA).

"We can't talk about a [Pfizer] vaccine that we are not yet administering as a country. We will not vaccinate until full authorisation is done by SAHPRA. We have a work stream that [deals] with anti-corruption and risk management.

"We are now focusing on control and prevention before dealing with it in a responding or reactive manner. We are being proactive. Until all papers have been filed, we are aware that the United States has given an emergency OK for its [Johnson & Johnson] rollout and papers have been submitted in this country."

Ntshavheni said SAPHRA and the US Food and Drug Administration have reached agreements to ensure that whatever was approved in the US could be used in South Africa to fast-track that process.

"… there is no worry about that. I don't know why there should have been criticism because there is no need for such," he added.

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options

Email Registration Success

Thank you, you have successfully subscribed to one or more of Creamer Media’s email newsletters. You should start receiving the email newsletters in due course.

Our email newsletters may land in your junk or spam folder. To prevent this, kindly add newsletters@creamermedia.co.za to your address book or safe sender list. If you experience any issues with the receipt of our email newsletters, please email subscriptions@creamermedia.co.za